SCA
RMTI icon

Stonebridge Capital Advisors’s Rockwell Medical RMTI Stock Holding History

Stonebridge Capital Advisors’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11
Closed -$227 – 705
2023
Q3 		$227 Buy
+11
New +$334 ﹤0.01% 893

Other funds holding RMTI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stonebridge Capital Advisors's RMTI Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Rockwell Medical (RMTI) in Q4 2023, closing a stake of 11 shares — an estimated $227 sold.

Stonebridge Capital Advisors first reported a position in RMTI in Q3 2023 and held it in 1 quarter. The position peaked at $227 in Q3 2023. 34 funds tracked by Wall St. Rank hold RMTI as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining Rockwell Medical position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 11 Rockwell Medical shares in Q4 2023, an estimated $227.
  • Stonebridge Capital Advisors first reported a position in Rockwell Medical in Q3 2023 and held it in 1 quarter.
  • Stonebridge Capital Advisors's Rockwell Medical position peaked at $227 in Q3 2023.
  • 34 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.